Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS receives record number of applications
2011-12-31

The University of the Free State (UFS) is looking forward to the start of the new academic year in January 2012, when thousands of new students will be joining the Kovsie family.

The UFS received almost 13 000 applications for studies in 2012. This is an increase of about 80% compared to the total number of applications received in 2010 for studies in 2011.

This increase is partly attributed to the university’s new method in approaching prospective students and the marketing initiatives followed during 2011. These included visits to various schools in the country by the Vice-Chancellor and Rector, Prof. Jonathan Jansen.

“This shows that the UFS is becoming a preferred place of study. Unfortunately, we can only take in about 4 000 first-years from these applications. We will, of course, choose the best and most diverse class of students,” says Prof. Jansen.

The university’s marketing initiatives will be intensified next year where students will take part as ambassadors in the university’s student recruitment campaigns for 2013.

Mr.Rudi Buys, The Dean of Student Affairs at the UFS, says Prof. Jansen’s visit to various schools in the country was very successful. This will be continued in 2012 and student leaders from residences, associations as well as the Student Representative Council will accompany him on these visits during the course of the year.

“These learners, just like our students, are part of a new generation of new democratic South Africans. Our students are excellent examples of youth leadership in the country and we are very excited about all our initiatives,” Mr Buys said.

The UFS is aware of the fact that learners will only receive their final Grade 12 results in January 2012. Final admission will therefore only be granted upon the submission of a certified copy of the matriculation results. Fax these results to 086 586 8947 or e-mail to applications@ufs.ac.za  as soon as it is available.

Important dates for Bloemfontein students

  • Friday and Saturday 13 & 14 January 2012: Welcoming of new first-years
  • Sunday 15 January: Gateway College life programme (Bloemfontein edition) begins)
  • Monday 16 January 2012: Registration starts 

Important dates for Qwaqwa students

  • Thursday 12 January 2012: Arrival of first-years
  • Friday 13 January 2012: Gateway College Life programme (Qwaqwa edition) begins.
  • Monday 16 January 2012: Registration starts

For more information, Bloemfontein students can contact Student Affairs at 051 401 9102 or send an e-mail to Cornelia Faasen at faasenc@ufs.ac.za . Qwaqwa students can contact Dulcie Malimabe at 058 718 5018 or send an e-mail to malimabedp@qwa.ufs.ac.za  

Media Release
Issued by:
Lacea Loader
Director: Strategic Communication
Telephone: +27 (0) 51 401 2584
+27 (0) 83 645 2454
E-mail: news@ufs.ac.za
Fax: +27 (0) 51 444 6393
Web: www.ufs.ac.za
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept